CHAOJIE CHEN: Open Payments
NPI 1275823700 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 26 payments from 8 companies in 2025. Trend: 2023 $260 · 2024 $324 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $150 |
| Insulet Corporation | 4 | $98 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
| PFIZER INC. | 2 | $32 |
| Novo Nordisk Inc | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: MAVYRET, Omnipod, GVOKE HYPOPEN, QULIPTA, MOUNJARO, NURTEC ODT, Wegovy, PIFELTRO.
Industry payments across NV — which companies pay providers there.
